BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25953391)

  • 1. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells.
    Yin CC; Tang G; Lu G; Feng X; Keating MJ; Medeiros LJ; Abruzzo LV
    Mod Pathol; 2015 Aug; 28(8):1130-7. PubMed ID: 25953391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.
    Gladstone DE; Blackford A; Cho E; Swinnen L; Kasamon Y; Gocke CD; Griffin CA; Bolaños-Meade J; Jones RJ
    Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):132-7. PubMed ID: 22285608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia.
    Gladstone DE; Swinnen L; Kasamon Y; Blackford A; Gocke CD; Griffin CA; Meade JB; Jones RJ
    Leuk Lymphoma; 2011 Oct; 52(10):1873-81. PubMed ID: 21851216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies.
    Yin CC; Peng J; Li Y; Kanagal-Shamanna R; Muzzafar T; DiNardo C; Khoury JD; Li S; Medeiros LJ; Wang SA; Tang G
    Mod Pathol; 2015 Aug; 28(8):1014-22. PubMed ID: 26044451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients With a History of Chemotherapy and Isolated del(20q) With Minimal Myelodysplasia Have an Indolent Course.
    Courville EL; Singh C; Yohe S; Linden MA; Naemi K; Berger M; Ustun C; McKenna RW; Dolan M
    Am J Clin Pathol; 2016 Apr; 145(4):459-66. PubMed ID: 27124938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia with t(14;18)(q32;q21).
    Tang G; Banks HE; Sargent RL; Medeiros LJ; Abruzzo LV
    Hum Pathol; 2013 Apr; 44(4):598-605. PubMed ID: 23084581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
    Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
    Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristics and prognostic analysis in 213 myeloid malignancy patients with del(20q): a report of a single-center case series.
    Pan J; Wu C; Xue Y; Qiu H; Chen S; Zhang J; Bai S; Wu Y; Wang Y; Shen J; Gong Y
    Cancer Genet; 2014 Mar; 207(3):51-6. PubMed ID: 24699042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.
    Liu YC; Miyazawa K; Sashida G; Kodama A; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Aug; 169(1):69-72. PubMed ID: 16875940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission.
    Sun J; Yin CC; Cui W; Chen SS; Medeiros LJ; Lu G
    Am J Clin Pathol; 2011 Mar; 135(3):391-7. PubMed ID: 21350093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
    Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
    Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q).
    Yoon J; Yun JW; Jung CW; Kim HJ; Kim SH
    J Clin Lab Anal; 2019 Sep; 33(7):e22951. PubMed ID: 31187545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and laboratory features of 13 cases of myeloid neoplasms with double del (20q)].
    Bai S; Wu C; Zhang J; Chen S; Pan J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):546-549. PubMed ID: 28777856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the long arm of chromosome 20 in a patient with small cell lymphocytic lymphoma.
    Cotter PD; Tumewu P; Browett PJ
    Cancer Genet Cytogenet; 1993 Oct; 70(2):142-3. PubMed ID: 7694789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.
    Kurtin PJ; Dewald GW; Shields DJ; Hanson CA
    Am J Clin Pathol; 1996 Nov; 106(5):680-8. PubMed ID: 8929482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion(20q) as the sole abnormality in plasma cell myeloma is not associated with plasma cells as identified by cIg FISH.
    White JS; Zordan A; Batzios C; Campbell LJ
    Cancer Genet; 2012 Dec; 205(12):644-52. PubMed ID: 23200818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.